Photocure Provides Update on Anticipated Commercial Availability of Karl Storz’s New Blue Light System in the United States
Oslo, Norway, July 27, 2022: Photocure ASA, The Bladder Cancer Company, announces that it has been informed by Karl Storz that the U.S. launch of the new high-definition blue light system has been delayed due to supply disruptions of certain capital equipment components. Based on current information, Photocure now expects commercial availability of the upgraded blue light system in late Q3 2022.The Company reports that five flexible blue light cystoscopy (BLC[®]) towers were installed in the U.S. during the second quarter of 2022. While no rigid BLC towers were available for placement